CClinicalTrials.gg
Status unknownNCT03440931Updated Mar 1, 2018

Monitoring Ovarian Cysts in Pregnancy

An observational study in Ovarian Cysts, sponsored by Guy's and St Thomas' NHS Foundation Trust. Status unknown. Open to female participants aged 16 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-03-01.

Sponsored by Guy's and St Thomas' NHS Foundation Trust · Observational

The sponsor has not verified this record recently (last verified Feb 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
16 Years to 50 Years
Sex
Female
01

Study summary

This prospective study will primarily aim to determine what monitoring is required of ovarian cysts when they are diagnosed in pregnancy, as well as what intervention, if any, is necessary. It also aims to identify the prevalence of ovarian cysts in pregnancy and the nature of these cysts, as well as their natural history throughout pregnancy.

Read the detailed description

The Royal College of Obstetricians and Gynaecologists currently publish guidelines for the management of ovarian cysts in both pre and post-menopausal women. The guidelines for pre-menopausal women do not specifically include pregnant women, and it is known from previous research that the characteristics of ovarian cysts can differ in pregnancy, and therefore appear different on ultrasound scan. Also, where intervention is needed, it is usually surgical which can have high risk implications in pregnancy.

The study will be conducted in the Early Pregnancy and Acute Gynaecology Unit at St. Thomas' Hospital. Any woman who presents with symptoms in early pregnancy (less than 18 weeks) is offered a transvaginal ultrasound scan. If, on this scan, they are found to have an ovarian cyst, they will be considered for the study. Once the ovarian cyst has initially been diagnosed, a confirmatory scan will be carried out by one of the investigators (ie. a clinical fellow, consultant gynaecologist or senior sonographer).

If the cyst is benign in nature and not the cause of acute symptoms, three more transvaginal scans will be carried out by one of the investigators at approximately 12 weeks and 20 weeks (in line with the nuchal translucency scan and anomaly scan), then at 6 weeks post partum. It is intended that all these patients will be managed without surgical intervention.

If there are concerns that the cyst is malignant, the participant would be investigated via the already established pathways. If the participant is at any point in acute pain and the cyst is thought to be the cause of this eg. ovarian torsion or cyst rupture, then a clinical decision would be made regarding surgical intervention.

The total study period will be up to 16 months. This includes a 6 month recruitment period, then following up each participant until 6 weeks post delivery.

02

Conditions studied

  • Ovarian Cysts

Browse trials for

03

Who can participate

Ages eligible
16 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Pregnant women (diagnosed on urinary HCG) who attend the Early Pregnancy Unit at St. Thomas' Hospital and undergo an early pregnancy ultrasound scan. If the scan also shows one or more ovarian cysts, they are eligible for the study, as per the criteria above.

Inclusion criteria

  • Age 16-50 Pregnant Scanned in the Early Pregnancy Unit at St. Thomas' Hospital (either as a walk in patient / a ward in-patient / referred from A\&E or another speciality) At least one ovarian cyst (excluding a corpus luteum)

Exclusion criteria

Exclusion Criteria:

  • Age \<16 (so as to avoid problems with consent / Gillick competence) Not pregnant (ie. attending the unit with acute gynaecology problem or for follow up after a miscarriage) Lacks capacity to consent Corpus luteal cyst only on ultrasound scan
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Interventions

  • Diagnostic testUltrasound scan

    Transvaginal ultrasound scan to assess ovaries

05

What researchers measure

Primary outcomes

  1. The proportion of ovarian cysts that are still visible at the final scan (6 weeks post partum)

    Time frame: 10 months

Secondary outcomes

  1. The nature of the ovarian cysts (i.e functional/dermoid/endometrioma/borderline/malignant)

    Time frame: 10 months

  2. The proportion of patients who required other imaging as well as ultrasound scans (eg. MRI)

    Time frame: 10 months

  3. The prevalence of ovarian cysts in pregnancy

    Time frame: 16 months

  4. The proportion of pregnant women who still have a corpus luteum at 20 weeks

    Time frame: 5 months

  5. The proportion of pregnant woman with ovarian cysts who require surgical intervention

    Time frame: 10 months

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03440931
Lead sponsor
Guy's and St Thomas' NHS Foundation Trust
Responsible party
Sponsor
First posted
Feb 22, 2018
Start date
Feb 2018 (estimated)
Primary completion
May 2019 (estimated)
Completion
May 2019 (estimated)
Last update
Mar 1, 2018

Study contacts

Catherine Magee, MBChB
Contact
catherine.magee@gstt.nhs.uk
02071880864
Catherine Magee, MBChB
principal investigator · Guys and St. Thomas' NHS Foundatiuon Trust

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion